Skip to main content
. Author manuscript; available in PMC: 2016 Jan 31.
Published in final edited form as: Liver Transpl. 2015 Feb;21(2):187–194. doi: 10.1002/lt.24042

Table 1.

Recipient characteristics of HCC liver transplant recipients.

Total
Population
(n=5002)
Donor Age
<60 (n=4162)
Donor Age
≥60 (n=840)
Local Share
(n=3957)
Non-local
(n=1045)
Recipient
characteristics
n (%) n (%) n (%) p value n (%) n (%) p value
Male 3872 (77.4) 3251 (78.1) 621 (73.9) 0.008 3068 (77.5) 804 (76.9) 0.68
Ethnicity
  White 3373 (67.4) 2814 (67.6) 559 (66.6) 0.55 2657 (67.2) 716 (68.5) 0.40
  Black 447 (8.9) 369 (8.9) 78 (9.3) 0.70 354 (9.0) 93 (8.9) 0.96
  Hispanic/Latino 684 (13.7) 567 (13.6) 117 (13.9) 0.81 550 (13.9) 134 (12.8) 0.37
  Asian 435 (8.7) 356 (8.6) 79 (9.4) 0.42 344 (8.7) 91 (8.7) 0.99
  Other/multi-race 63 (1.3) 56 (1.4) 7 (0.8) 0.22 52 (1.3) 11 (1.0) 0.50
MELD at transplant
  22 2666 (53.3) 2225 (53.5) 441 (52.5) 0.61 1997 (50.5) 669 (64.0) <0.001
  23–24 44 (0.9) 37 (0.9) 7 (0.8) 0.87 29 (0.7) 15 (1.4) 0.03
  25 1199 (24.0) 983 (23.6) 216 (25.7) 0.19 1031 (26.1) 168 (16.1) <0.001
  26–27 110 (2.2) 83 (2.0) 27 (3.2) 0.03 84 (2.1) 26 (2.5) 0.47
  28 471 (9.4) 399 (9.6) 72 (8.6) 0.36 407 (10.3) 64 (6.1) <0.001
  29–30 245 (4.9) 202 (4.8) 43 (5.1) 0.74 198 (5.0) 47 (4.5) 0.50
  31 117 (2.3) 98 (2.4) 19 (2.3) 0.87 96 (2.4) 21 (2.0) 0.43
  32–40 150 (3.0) 135 (3.2) 15 (1.8) 0.02 115 (2.9) 35 (3.4) 0.46
ICU at transplant 72 (1.4) 61 (1.5) 11 (1.3) 0.73 52 (1.3) 20 (1.9) 0.15
Diagnosis
  HCV 3108 (62.1) 2662 (64.0) 446 (53.1) <0.001 2465 (62.3) 643 (61.5) 0.65
  Alcoholic cirrhosis 422 (8.4) 321 (7.7) 101 (12.0) <0.001 329 (8.3) 93 (8.9) 0.54
  Non-cholestatic cirrhosis 287 (5.7) 228 (5.5) 59 (7.0) 0.08 232 (5.9) 55 (5.3) 0.46
  HBV 290 (5.8) 232 (5.6) 58 (6.9) 0.13 233 (5.9) 57 (5.4) 0.59
  NASH 215 (4.3) 167 (4.0) 48 (5.7) 0.03 176 (4.4) 39 (3.7) 0.31
  Other 680 (13.6) 552 (13.3) 128 (15.2) 0.13 522 (13.2) 158 (15.1) 0.10
Median (IQR) Median (IQR) Median (IQR) p value Median (IQR) Median (IQR) p value
Age at transplant 57 (53–62) 57 (53–62) 58 (54–64) <0.001 57 (53–62) 58 (53–63) 0.16
Waitlist time (days) 77 (27–158) 76 (26–157) 80 (30–168) 0.37 87 (28–165) 53 (22–119) <0.001
Post-transplant follow-up (days) 753 (383–1323) 756 (385–1367) 742 (369–1124) 0.002 756 (383–1348) 745 (381–1188) 0.21
HHS Vulnerability Disclosure